Skip to main content
Erschienen in: Tumor Biology 12/2015

01.12.2015 | Research Article

Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses

verfasst von: Ugo Borges Pinheiro, Carlos Alberto de Carvalho Fraga, Danilo Cangussu Mendes, Lucyana Conceição Farias, Cláudio Marcelo Cardoso, Christine Mendes Silveira, Marcos Flávio Silveira Vasconcelos D̕Angelo, Kimberly Marie Jones, Sérgio Henrique Souza Santos, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães

Erschienen in: Tumor Biology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

It is estimated that 7.6 million people will die as a consequence of head and neck squamous cell carcinoma (HNSCC). Genetic predisposition has emerged as an important risk factor in the development and prognosis of HNSCC. Considering this, the aim of the current study is to assess whether codon 72 SNP of the TP53 gene (rs1042522) is associated with an increased odds ratio of developing HNSCC or with a worse prognosis in patients with HNSCC. Analysis of the rs1042522 in HNSCC patients and in control individuals. Differences between the case and control groups were determined using chi-squared tests. Multivariate analysis was performed to evaluate the odds ratio of HNSCC. Fussy C Means Clustering was to cluster HNSCC patients for survival analyses. Time of survival was calculated using the Kaplan-Meier estimator and comparing this to the log rank test. Statistical significance was set at p < 0.05. A total of 71.4 % of the Arg/Arg genotype were from HNSCC patients, while only 28.6 % of Arg/Arg genotype were found in the control group. Logistic regression demonstrated that the Arg/Arg genotype, smoking, and alcohol consumption increase the odds ratio of HNSCC. No association between TP53 codon 72 polymorphism and P53 expression. No association between rs1042522 and survival or prognoses was observed. This study identified that individuals carrying the arginine allele at rs1042522 have an increased odds ratio of HNSCC. However, no association between codon 72 SNP of the TP53 gene and HNSCC prognosis or P53 expression was observed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat (INCA) NCI: Estimate 2014: Brazilian cancer incidence.: Instituto Nacional deCâncer. 2014. (INCA) NCI: Estimate 2014: Brazilian cancer incidence.: Instituto Nacional deCâncer. 2014.
3.
Zurück zum Zitat De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (hnscc) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009;45:777–82.CrossRefPubMed De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (hnscc) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009;45:777–82.CrossRefPubMed
4.
Zurück zum Zitat Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9–17.CrossRefPubMed Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9–17.CrossRefPubMed
5.
Zurück zum Zitat Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev. 1991;1:67–73. Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev. 1991;1:67–73.
6.
Zurück zum Zitat Wang JR, Gramling SJ, Goldstein DP, Cheng D, Chen D, Azad AK, et al. Association of two brm promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis. 2013;34:1012–7.CrossRefPubMed Wang JR, Gramling SJ, Goldstein DP, Cheng D, Chen D, Azad AK, et al. Association of two brm promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis. 2013;34:1012–7.CrossRefPubMed
7.
Zurück zum Zitat Thakur N, Hussain S, Nasare V, Das BC, Basir SF, Bharadwaj M. Association analysis of p16 (cdkn2a) and rb1 polymorphisms with susceptibility to cervical cancer in indian population. Mol Biol Rep. 2012;39:407–14.CrossRefPubMed Thakur N, Hussain S, Nasare V, Das BC, Basir SF, Bharadwaj M. Association analysis of p16 (cdkn2a) and rb1 polymorphisms with susceptibility to cervical cancer in indian population. Mol Biol Rep. 2012;39:407–14.CrossRefPubMed
8.
Zurück zum Zitat Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, et al. Dnmt3b (c46359t) polymorphisms and immunoexpression of dnmt3b and dnmt1 proteins in oral lichen planus. Pathobiology. 2012;79:18–23.CrossRefPubMed Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, et al. Dnmt3b (c46359t) polymorphisms and immunoexpression of dnmt3b and dnmt1 proteins in oral lichen planus. Pathobiology. 2012;79:18–23.CrossRefPubMed
9.
Zurück zum Zitat Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS, Marques-Silva L, et al. High hif-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4:87. Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS, Marques-Silva L, et al. High hif-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4:87.
10.
Zurück zum Zitat Fraga CA, Sousa AA, Correa GT, Jorge AS, Jesus SF, Jones KM, et al. High hypoxia-inducible factor-1alpha expression genotype associated with eastern cooperative oncology group performance in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4:77. Fraga CA, Sousa AA, Correa GT, Jorge AS, Jesus SF, Jones KM, et al. High hypoxia-inducible factor-1alpha expression genotype associated with eastern cooperative oncology group performance in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4:77.
11.
Zurück zum Zitat Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, et al. Fgfr4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PLoS One. 2012;7:e50747.CrossRefPubMedPubMedCentral Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, et al. Fgfr4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PLoS One. 2012;7:e50747.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lee JM, Yang PW, Yang SY, Chuang TH, Tung EC, Chen JS, et al. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Ann Surg. 2011;253:918–27.CrossRefPubMed Lee JM, Yang PW, Yang SY, Chuang TH, Tung EC, Chen JS, et al. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Ann Surg. 2011;253:918–27.CrossRefPubMed
13.
Zurück zum Zitat Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, et al. Aurora-a and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in caucasians. Clin Cancer Res. 2007;13:3100–4.CrossRefPubMedPubMedCentral Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, et al. Aurora-a and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in caucasians. Clin Cancer Res. 2007;13:3100–4.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, et al. Haplotypes of two variants in p16 (cdkn2/mts-1/ink4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:640–5.PubMed Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, et al. Haplotypes of two variants in p16 (cdkn2/mts-1/ink4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:640–5.PubMed
15.
Zurück zum Zitat Stefani FA, Viana MB, Dupim AC, Brito JA, Gomez RS, da Costa JE, et al. Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues. Immunobiology. 2012;218:2012–7. Stefani FA, Viana MB, Dupim AC, Brito JA, Gomez RS, da Costa JE, et al. Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues. Immunobiology. 2012;218:2012–7.
16.
Zurück zum Zitat Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases. Cytokine Growth Factor Rev. 2009;20:223–32.CrossRefPubMed Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases. Cytokine Growth Factor Rev. 2009;20:223–32.CrossRefPubMed
17.
Zurück zum Zitat Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, Dos Santos EP, Silva TF, et al. Association of -308 tnf-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47:888–94.CrossRefPubMed Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, Dos Santos EP, Silva TF, et al. Association of -308 tnf-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47:888–94.CrossRefPubMed
18.
Zurück zum Zitat Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, et al. Effect of age on the association between p16cdkn2a methylation and dnmt3b polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010;37:167–76.PubMed Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, et al. Effect of age on the association between p16cdkn2a methylation and dnmt3b polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010;37:167–76.PubMed
19.
Zurück zum Zitat McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986;83:130–4.CrossRefPubMedPubMedCentral McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986;83:130–4.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Xu T, Xu ZC, Zou Q, Yu B, Huang XE. P53 arg72pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in asians but not caucasians. Asian Pac J Cancer Prev. 2012;13:2349–54.CrossRefPubMed Xu T, Xu ZC, Zou Q, Yu B, Huang XE. P53 arg72pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in asians but not caucasians. Asian Pac J Cancer Prev. 2012;13:2349–54.CrossRefPubMed
23.
Zurück zum Zitat Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. Tp53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10:772–84.CrossRefPubMed Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. Tp53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10:772–84.CrossRefPubMed
24.
Zurück zum Zitat Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol. 2004;164:1233–41.CrossRefPubMedPubMedCentral Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol. 2004;164:1233–41.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.CrossRefPubMed Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.CrossRefPubMed
26.
Zurück zum Zitat Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS, et al. A high hif-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol. 2012;48:130–5.CrossRefPubMed Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS, et al. A high hif-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol. 2012;48:130–5.CrossRefPubMed
27.
Zurück zum Zitat Bezdek JC. Pattern recognition with fuzzy objective function algorithms. New York: Plenum Press; 1981.CrossRef Bezdek JC. Pattern recognition with fuzzy objective function algorithms. New York: Plenum Press; 1981.CrossRef
28.
Zurück zum Zitat Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. Tp53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26:2157–65.CrossRefPubMed Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. Tp53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26:2157–65.CrossRefPubMed
29.
Zurück zum Zitat Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32:1–11.PubMedPubMedCentral Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32:1–11.PubMedPubMedCentral
30.
Zurück zum Zitat Correa GT, Bandeira GA, Cavalcanti BG, Santos FB, Neto JF, Guimaraes AL, et al. Analysis of ecog performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer. 2012;20:2679–85.CrossRefPubMed Correa GT, Bandeira GA, Cavalcanti BG, Santos FB, Neto JF, Guimaraes AL, et al. Analysis of ecog performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer. 2012;20:2679–85.CrossRefPubMed
31.
Zurück zum Zitat Suresh K, Chandirasekar R, Kumar BL, Venkatesan R, Sasikala K. No association between the trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a south indian population. Asian Pac J Cancer Prev. 2010;11:1749–53.PubMed Suresh K, Chandirasekar R, Kumar BL, Venkatesan R, Sasikala K. No association between the trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a south indian population. Asian Pac J Cancer Prev. 2010;11:1749–53.PubMed
32.
Zurück zum Zitat Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123–30.CrossRefPubMed Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123–30.CrossRefPubMed
33.
Zurück zum Zitat Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the arg allele is preferentially retained in tumours arising in arg/pro germline heterozygotes. Br J Cancer. 2002;87:1013–8.CrossRefPubMedPubMedCentral Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the arg allele is preferentially retained in tumours arising in arg/pro germline heterozygotes. Br J Cancer. 2002;87:1013–8.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Brant O, Hoffmann M, Kanappilly A, Gorogh T, Gottschlich S. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region. Anticancer Res. 2007;27:3301–5.PubMed Brant O, Hoffmann M, Kanappilly A, Gorogh T, Gottschlich S. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region. Anticancer Res. 2007;27:3301–5.PubMed
35.
Zurück zum Zitat Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. Tp53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of brazilian women with cervical lesions. J Toxicol Environ Health A. 2010;73:888–900.CrossRefPubMed Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. Tp53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of brazilian women with cervical lesions. J Toxicol Environ Health A. 2010;73:888–900.CrossRefPubMed
36.
Zurück zum Zitat Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, et al. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol. 2013;32:19–27.CrossRefPubMed Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, et al. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol. 2013;32:19–27.CrossRefPubMed
37.
Zurück zum Zitat Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.CrossRefPubMed Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.CrossRefPubMed
38.
Zurück zum Zitat Jing G, Lv K, Jiao X. The p53 codon 72 polymorphism and the risk of oral cancer in a chinese han population. Genet Test Mol Biomarkers. 2012;16:1149–52.CrossRefPubMed Jing G, Lv K, Jiao X. The p53 codon 72 polymorphism and the risk of oral cancer in a chinese han population. Genet Test Mol Biomarkers. 2012;16:1149–52.CrossRefPubMed
39.
Zurück zum Zitat Jiang M, Chiu SY, Hsu W. Sumo-specific protease 2 in mdm2-mediated regulation of p53. Cell Death Differ. 2011;18:1005–15.CrossRefPubMed Jiang M, Chiu SY, Hsu W. Sumo-specific protease 2 in mdm2-mediated regulation of p53. Cell Death Differ. 2011;18:1005–15.CrossRefPubMed
40.
Zurück zum Zitat Linder S, Parrado C, Falkmer UG, Blasjo M, Sundelin P, von Rosen A. Prognostic significance of ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies mib-1 and do-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 1997;76:54–9.CrossRefPubMedPubMedCentral Linder S, Parrado C, Falkmer UG, Blasjo M, Sundelin P, von Rosen A. Prognostic significance of ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies mib-1 and do-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 1997;76:54–9.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, et al. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol. 2014;44:232–40.CrossRefPubMed Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, et al. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol. 2014;44:232–40.CrossRefPubMed
42.
Zurück zum Zitat de Oliveira MV, Pereira Gomes EP, Pereira CS, de Souza LR, Barros LO, Mendes DC, et al. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma. Appl Immunohistochem Mol Morphol: AIMM / Off Publ Soc Appl Immunohistochem. 2013;21:444–51.CrossRef de Oliveira MV, Pereira Gomes EP, Pereira CS, de Souza LR, Barros LO, Mendes DC, et al. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma. Appl Immunohistochem Mol Morphol: AIMM / Off Publ Soc Appl Immunohistochem. 2013;21:444–51.CrossRef
43.
Zurück zum Zitat Wang Z, Sturgis EM, Guo W, Song X, Zhang F, Xu L, et al. Association of combined p73 and p53 genetic variants with tumor hpv16-positive oropharyngeal cancer. PLoS One. 2012;7:e35522.CrossRefPubMedPubMedCentral Wang Z, Sturgis EM, Guo W, Song X, Zhang F, Xu L, et al. Association of combined p73 and p53 genetic variants with tumor hpv16-positive oropharyngeal cancer. PLoS One. 2012;7:e35522.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of hpv in head and neck squamous cell carcinoma. Cancer Res. 2012;72:5004–13.CrossRefPubMedPubMedCentral Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of hpv in head and neck squamous cell carcinoma. Cancer Res. 2012;72:5004–13.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene. 2004;23:3328–37.CrossRefPubMed Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene. 2004;23:3328–37.CrossRefPubMed
Metadaten
Titel
Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses
verfasst von
Ugo Borges Pinheiro
Carlos Alberto de Carvalho Fraga
Danilo Cangussu Mendes
Lucyana Conceição Farias
Cláudio Marcelo Cardoso
Christine Mendes Silveira
Marcos Flávio Silveira Vasconcelos D̕Angelo
Kimberly Marie Jones
Sérgio Henrique Souza Santos
Alfredo Maurício Batista de Paula
André Luiz Sena Guimarães
Publikationsdatum
01.12.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 12/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3677-7

Weitere Artikel der Ausgabe 12/2015

Tumor Biology 12/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.